You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 765 The first-in-class small molecule TREX1 inhibitor CPI-381 demonstrates type I IFN induction and sensitization of tumors to immune checkpoint blockade

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
765 The first-in-class small molecule TREX1 inhibitor CPI-381 demonstrates type I IFN induction and sensitization of tumors to immune checkpoint blockade

 

Online download statistics by month:

Online download statistics by month: November 2021 to November 2024

AbstractFullPdf
Nov 2021242028
Dec 2021114019
Jan 2022114031
Feb 2022104028
Mar 2022166038
Apr 2022154035
May 2022259053
Jun 2022144036
Jul 2022292056
Aug 2022208042
Sep 2022246034
Oct 2022292038
Nov 2022276056
Dec 2022264048
Jan 2023248067
Feb 2023310067
Mar 2023332067
Apr 2023294056
May 2023284044
Jun 2023310043
Jul 2023232034
Aug 2023188041
Sep 2023200036
Oct 2023264036
Nov 2023172019
Dec 2023180031
Jan 2024154027
Feb 2024128018
Mar 2024338053
Apr 2024240043
May 2024260040
Jun 2024200025
Jul 2024158026
Aug 2024236030
Sep 2024210027
Oct 2024216033
Nov 2024158040
Total818701445